Decreased expression of heparanase in glioblastoma multiforme

Journal of Neurosurgery

Volumn 102, Issue 3, 2005, Pages 513-521

  Ueno, Yushi ^b   Yamamoto, Masaaki ^a   Vlodavsky, Israel ^b   Pecker, Iris ^b   Ohshima, Kohichi ^b   Fukushima, Takeo ^b  

^a FUKUOKA UNIVERSITY   (Japan)

^b NONE

Author keywords

Glioblastoma multiforme; Heparanase; Metastasis; Metastatic brain tumor

Indexed keywords

HEPARANASE; MESSENGER RNA; PARAFFIN; BETA GLUCURONIDASE;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; ANIMAL; BAGG ALBINO MOUSE; BRAIN TUMOR; ENZYMOLOGY; FEMALE; GENETICS; METASTASIS; MOUSE; NUDE MOUSE;

ANIMALS; BRAIN NEOPLASMS; DOWN-REGULATION; FEMALE; GLIOBLASTOMA; GLUCURONIDASE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 16244378275     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/jns.2005.102.3.0513     Document Type: Article

References (44)

1. Aguirre-Ghiso JA, Frankel P, Farias EF, Lu Z, Jiang H, Olsen A, et al: RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases. Oncogene 18:4718-4725, 1999
2. Aznavoorian S, Murphy AN, Stetler-Stevenson WG, Liotta CA: Molecular aspects of tumor cell invasion and metastasis. Cancer 71:1368-1383, 1993
3. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, et al: Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68:729-777, 1999
4. Blasi F: Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Bioessays 15:105-111, 1993
5. de Vries TJ, Verheijen JH, de Bart AC, Weidle UH, Ruiter DJ, van Muijen GN: Decreased expression of both the low-density lipoprotein receptor-related protein/alpha(2)-macroglobulin receptor and its receptor-associated protein in late stages of cutaneous melanocytic tumor progression. Cancer Res 56:1432-1439, 1996
6. Dempsey LA, Brunn GJ, Platt JL: Heparinase, a potential regulator of cell-matrix interactions. Trends Biochem Sci 25:349-351, 2000
7. Eccles SA: Heparinase: breaking down barriers in tumors. Nat Med 5:735-736, 1999
8. El-Assal ON, Yamanoi A, Ono T, Kohno H, Nagasue N: The clinicopathological significance of heparinase and basic fibroblast growth factor expressions in hepatocellular carcinoma. Clin Cancer Res 7:1299-1305, 2001
9. Foxall C, Holme KR, Liang W, Wei Z: An enzyme-linked immunosorbent assay using biotinylated heparan sulfate to evaluate the interactions of heparin-like molecules and basic fibroblast growth factor. Anal Biochem 231:366-373, 1995
10. Freeman C, Browne AM, Parish CR: Evidence that platelet and tumour heparinases are similar enzymes. Biochem J 342:361-368, 1999
11. Friedmann Y, Vlodavsky I, Aingorn H, Aviv A, Peretz T, Pecker I, et al: Expression of heparinase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis. Am J Pathol 157:1167-1175, 2000
12. Giese A, Westphal M: Glioma invasion in the central nervous system. Neurosurgery 39:235-252, 1996
13. Gleave JRW: Surgery for primary brain tumours, in Bleehen NM (ed): Tumours of the Brain. Berlin: Springer-Verlag, 1986, pp 101-120
14. Gohji K, Hirano H, Okamoto M, Kitazawa S, Toyoshima M, Dong J, et al: Expression of three extracellular matrix degradative enzymes in bladder cancer. Int J Cancer 95:295-301, 2001
15. Heid CA, Stevens J, Livak KJ, Williams PM: Real time quantitative PCR. Genome Res 6:986-994, 1996
16. Hulett MD, Freeman C, Hamdorf BJ, Baker RT, Harris MJ, Parish CR: Cloning of mammalian heparinase, an important enzyme in tumor invasion and metastasis. Nat Med 5:803-809, 1999
17. Ihrcke NS, Parker W, Reissner KJ, Platt JL: Regulation of platelet heparinase during inflammation: role of pH and proteinases. J Cell Physiol 175:255-267, 1998
18. Itoh Y, Nagase H: Matrix metalloproteinases in cancer. Essays Biochem 38:21-36, 2002
19. Kleihues P, Burger PC, Scheithauer BW (eds): Histological Typing of Tumors of the Central Nervous System, ed 2. Berlin: Springer-Verlag, 1993
20. Koliopanos A, Friess H, Kleeff J, Shi X, Liao Q, Pecker I, et al: Heparinase expression in primary and metastatic pancreatic cancer. Cancer Res 61:4655-4659, 2001
21. Kosir MA, Wang W, Zukowski KL, Tromp G, Barber J: Degradation of basement membrane by prostate tumor heparinase. J Surg Res 81:42-47, 1999
22. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64:327-336, 1991
23. Marchetti D, Li J, Shen R: Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparinase. Cancer Res 60:4767-4770, 2000
24. Maxhimer JB, Quiros RM, Stewart R, Dowlatshahi K, Gattuso P, Fan M, et al: Heparinase-1 expression is associated with the metastatic potential of breast cancer. Surgery 132:326-333, 2002
25. Miao HQ, Elkin M, Aingorn E, Ishai-Michaeli R, Stein CA, Vlodavsky I: Inhibition of heparinase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides. Int J Cancer 83:424-431, 1999
26. Nakajima M, Irimura T, Di Ferrante D, Di Ferrante N, Nicolson GL: Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. Science 220:611-613, 1983
27. Nakajima M, Irimura T, Nicolson GL: Heparinases and tumor metastasis. J Cell Biochem 36:157-167, 1988
28. Nishikawa R, Ji XD, Harmon RC, Lazar CS, Gill GN, Cavenee WK, et al: A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci USA 91:7727-7731, 1994
29. Parish CR, Freeman C, Hulett MD: Heparinase: a key enzyme involved in cell invasion. Biochim Biophys Acta 1471:M99-M108, 2001
30. Pikas DS, Li JP, Vlodavsky I, Lindahl U: Substrate specificity of heparinases from human hepatoma and platelets. J Biol Chem 273:18770-18777, 1998
31. Pollanen J, Stephens RW, Vaheri A: Directed plasminogen activation at the surface of normal and malignant cells. Adv Cancer Res 57:273-328, 1991
32. Poste G, Fidler IJ: The pathogenesis of cancer metastasis. Nature 283:139-176, 1980
33. Russell DS, Rubinstein LJ (eds): Pathology of Tumors of the Nervous System. London: Edward Arnold, 1989
34. Sivaram P, Obunike JC, Goldberg IJ: Lysolecithin-induced alteration of subendothelial heparan sulfate proteoglycans increases monocyte binding to matrix. J Biol Chem 270:29760-29765, 1995
35. Tang W, Nakamura Y, Tsujimoto M, Sato M, Wang X, Kurozumi K, et al: Heparinase: a key enzyme in invasion and metastasis of gastric carcinoma. Mod Pathol 15:593-598, 2002
36. Toyoshima M, Nakajima M: Human heparinase. Purification, characterization, cloning, and expression. J Biol Chem 274:24153-24160, 1999
37. Vlodavsky I, Friedmann Y: Molecular properties and involvement of heparinase in cancer metastasis and angiogenesis. J Clin Invest 108:341-347, 2001
38. Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Ishai-Michaeli R, et al: Mammalian heparinase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 5:793-802, 1999
39. Vlodavsky I, Fuks Z, Bar-Ner M, Ariav Y, Schirrmacher V: Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis. Cancer Res 43:2704-2711, 1983
40. Yamamoto M, Ikeda K, Ohshima K, Tsugu H, Kimura H, Tomonaga M: Increased expression of low density lipoprotein receptorrelated protein/a2-macroglobulin receptor in human malignant astrocytomas. Cancer Res 57:2799-2805, 1997
41. Yamamoto M, Mohanam S, Sawaya R, Fuller GN, Seiki M, Sato H, et al: Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumor in vivo and in vitro. Cancer Res 56:384-392, 1996
42. Yamamoto M, Sawaya R, Mohanam S, Bindal AK, Bruner JM, Oka K, et al: Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo. Cancer Res 54:3656-3661, 1994
43. Yamamoto M, Ueno Y, Hayashi S, Fukushima T: The role of proteolysis in tumor invasiveness in glioblastoma and metastatic brain tumors. Anticancer Res 22:4265-4268, 2002
44. Zetser A, Bashenko Y, Miao HQ, Vlodavsky I, Ilan N: Heparinase affects adhesive and tumorigenic potential of human glioma cells. Cancer Res 63:7733-7741, 2003